Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Caveolin-1 Protein (DYKDDDDK Tag)

Cette protéine MNP Membrane Nanoparticle Caveolin-1 est produite dans HEK-293 Cells.
N° du produit ABIN7597222
1.669,23 €
Plus frais de livraison 40,00 € et TVA
50 μg
Destination: France
Envoi sous 10 à 13 jours ouvrables

Aperçu rapide pour Caveolin-1 Protein (DYKDDDDK Tag) (ABIN7597222)

Antigène

Voir toutes Caveolin-1 (CAV1) Protéines
Caveolin-1 (CAV1) (Caveolin 1, Caveolae Protein, 22kDa (CAV1))

Type de proteíne

MNP Membrane Nanoparticle

Origine

  • 7
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Source

  • 20
  • 14
  • 1
  • 1
  • 1
  • 1
  • 1
HEK-293 Cells
  • Purification/Conjugué

    Cette Caveolin-1 protéine est marqué à la DYKDDDDK Tag.

    Fonction

    Human CAV1 full length protein-MNP

    Attributs du produit

    Plasma membrane-coated nanoparticles (MNPs) have been used in various applications, including delivery of therapeutic agents and induction of immune responses et al. Unlike the conventional strategies, MNPs directly leverage intact and natural functions of cell membranes, and show high biocompatibility, specificity, and low side effects. Our optimized MNPs platform for the full-length membrane protein production uses membrane coating technology and a HEK293 based expression platform. The high-purity plasma membrane-coated nanoparticles were produced by extrusion after membrane extraction from the host HEK293 cells containing the overexpressed target proteins.
  • Vous souhaitez d'autres options pour ce Protein ?

    !
    Découvrez nos protéines personnalisées prédéfinies et nos services de protéines sur mesure !

    Votre projet nécessite-t-il une personnalisation supplémentaire ? Contactez-nous et découvrez nos solutions protéiques sur mesure

  • Commentaires

    Advantages of MNP:

    • High display density of target membrane proteins
    • Native structure and orientation of transmembrane protein
    • soluble in aqueous solutions for routine biochemical analysis
    • Detergent-free purification process
    • Strong immunogenicity
    • Works for MPs that can´t be produced via VLPs and EXos
    Limitations of MNP:
    • Lack of accurate quantification of the target membrane proteins.
    • Need to develop special SPR assayx.
    • Cell membranes contain housekeeping proteins that can result in immune response dilution.
    • Some membrane proteins can´t be enriched on membrane.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Buffer

    Lyophilized from PBS. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

    Date de péremption

    12 months
  • Antigène

    Caveolin-1 (CAV1) (Caveolin 1, Caveolae Protein, 22kDa (CAV1))

    Autre désignation

    CAV1

    Sujet

    BSCL3, CGL3, LCCNS, MSTP085, PPH3, VIP21
    The scaffolding protein is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1.

    Poids moléculaire

    The human full length CAV1 protein has a MW of 20.3 kDa

    UniProt

    Q03135

    Pathways

    Maintenance of Protein Location, Signaling Events mediated by VEGFR1 and VEGFR2, Negative Regulation of Transporter Activity, VEGFR1 Specific Signals
Vous êtes ici:
Chat with us!